nodes	percent_of_prediction	percent_of_DWPC	metapath
Medrysone—NR3C1—Fluoxymesterone—breast cancer	0.257	1	CbGbCtD
Medrysone—Dydrogesterone—Exemestane—breast cancer	0.0733	0.113	CrCrCtD
Medrysone—Dydrogesterone—Fluoxymesterone—breast cancer	0.0508	0.0782	CrCrCtD
Medrysone—Megestrol acetate—Fluoxymesterone—breast cancer	0.0443	0.0681	CrCrCtD
Medrysone—Loteprednol—Exemestane—breast cancer	0.0401	0.0617	CrCrCtD
Medrysone—Medroxyprogesterone Acetate—Fluoxymesterone—breast cancer	0.0394	0.0606	CrCrCtD
Medrysone—Methylprednisolone—Exemestane—breast cancer	0.0375	0.0577	CrCrCtD
Medrysone—Testosterone—Exemestane—breast cancer	0.0375	0.0577	CrCrCtD
Medrysone—Prednisolone—Exemestane—breast cancer	0.0367	0.0564	CrCrCtD
Medrysone—Hydrocortamate—Fluoxymesterone—breast cancer	0.0355	0.0547	CrCrCtD
Medrysone—Cortisone acetate—Fluoxymesterone—breast cancer	0.0344	0.053	CrCrCtD
Medrysone—Progesterone—Fluoxymesterone—breast cancer	0.0299	0.046	CrCrCtD
Medrysone—Testosterone Propionate—Fluoxymesterone—breast cancer	0.0299	0.046	CrCrCtD
Medrysone—Methyltestosterone—Fluoxymesterone—breast cancer	0.0292	0.0449	CrCrCtD
Medrysone—Loteprednol—Fluoxymesterone—breast cancer	0.0278	0.0428	CrCrCtD
Medrysone—Fluorometholone—Fluoxymesterone—breast cancer	0.0278	0.0428	CrCrCtD
Medrysone—Testosterone—Fluoxymesterone—breast cancer	0.026	0.04	CrCrCtD
Medrysone—Prednisolone—Fluoxymesterone—breast cancer	0.0254	0.0391	CrCrCtD
Medrysone—Hydrocortisone—Fluoxymesterone—breast cancer	0.0244	0.0376	CrCrCtD
Medrysone—Nerve injury—Paclitaxel—breast cancer	0.00187	0.052	CcSEcCtD
Medrysone—Glaucoma—Toremifene—breast cancer	0.00176	0.049	CcSEcCtD
Medrysone—Impaired healing—Melphalan—breast cancer	0.00161	0.0447	CcSEcCtD
Medrysone—Viral infection—Exemestane—breast cancer	0.00129	0.036	CcSEcCtD
Medrysone—Eye irritation—Letrozole—breast cancer	0.00121	0.0338	CcSEcCtD
Medrysone—Viral infection—Letrozole—breast cancer	0.00115	0.0319	CcSEcCtD
Medrysone—Visual disturbance—Exemestane—breast cancer	0.000894	0.0249	CcSEcCtD
Medrysone—Visual impairment—Toremifene—breast cancer	0.000642	0.0179	CcSEcCtD
Medrysone—Keratitis—Paclitaxel—breast cancer	0.00063	0.0175	CcSEcCtD
Medrysone—Stinging—Fluorouracil—breast cancer	0.000592	0.0165	CcSEcCtD
Medrysone—Impaired healing—Methotrexate—breast cancer	0.000577	0.016	CcSEcCtD
Medrysone—Visual impairment—Exemestane—breast cancer	0.000565	0.0157	CcSEcCtD
Medrysone—Eye irritation—Fluorouracil—breast cancer	0.000562	0.0156	CcSEcCtD
Medrysone—Viral infection—Mitoxantrone—breast cancer	0.000554	0.0154	CcSEcCtD
Medrysone—Vision blurred—Toremifene—breast cancer	0.000547	0.0152	CcSEcCtD
Medrysone—Visual disturbance—Tamoxifen—breast cancer	0.000544	0.0151	CcSEcCtD
Medrysone—Hypersensitivity—Fluoxymesterone—breast cancer	0.000541	0.0151	CcSEcCtD
Medrysone—Conjunctivitis—Raloxifene—breast cancer	0.000535	0.0149	CcSEcCtD
Medrysone—SERPINA6—pituitary gland—breast cancer	0.000534	0.0919	CbGeAlD
Medrysone—Keratitis—Capecitabine—breast cancer	0.000517	0.0144	CcSEcCtD
Medrysone—SERPINA6—female reproductive system—breast cancer	0.000489	0.0841	CbGeAlD
Medrysone—Eye irritation—Paclitaxel—breast cancer	0.000478	0.0133	CcSEcCtD
Medrysone—SERPINA6—adrenal gland—breast cancer	0.000477	0.0821	CbGeAlD
Medrysone—Pain—Carboplatin—breast cancer	0.000473	0.0132	CcSEcCtD
Medrysone—SERPINA6—bone marrow—breast cancer	0.000462	0.0794	CbGeAlD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—AFP—breast cancer	0.000461	0.0101	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—RXRB—breast cancer	0.000453	0.00993	CbGpPWpGaD
Medrysone—Viral infection—Paclitaxel—breast cancer	0.000452	0.0126	CcSEcCtD
Medrysone—NR3C1—nipple—breast cancer	0.000428	0.0737	CbGeAlD
Medrysone—Vision blurred—Letrozole—breast cancer	0.000427	0.0119	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptors—RARB—breast cancer	0.000427	0.00937	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—KRT5—breast cancer	0.000422	0.00924	CbGpPWpGaD
Medrysone—SERPINA6—endocrine gland—breast cancer	0.000414	0.0712	CbGeAlD
Medrysone—Dydrogesterone—PGR—breast cancer	0.000413	0.0746	CrCbGaD
Medrysone—Pain—Fulvestrant—breast cancer	0.00041	0.0114	CcSEcCtD
Medrysone—Eye irritation—Docetaxel—breast cancer	0.000405	0.0113	CcSEcCtD
Medrysone—Pain—Toremifene—breast cancer	0.000405	0.0113	CcSEcCtD
Medrysone—Eye irritation—Capecitabine—breast cancer	0.000393	0.0109	CcSEcCtD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—breast cancer	0.000392	0.00859	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—NR2F1—breast cancer	0.000385	0.00843	CbGpPWpGaD
Medrysone—Hypersensitivity—Lapatinib—breast cancer	0.000384	0.0107	CcSEcCtD
Medrysone—Visual disturbance—Irinotecan—breast cancer	0.000384	0.0107	CcSEcCtD
Medrysone—Keratitis—Epirubicin—breast cancer	0.00036	0.01	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—EBF1—breast cancer	0.000358	0.00784	CbGpPWpGaD
Medrysone—Pain—Exemestane—breast cancer	0.000356	0.00991	CcSEcCtD
Medrysone—NR3C1—embryo—breast cancer	0.000353	0.0608	CbGeAlD
Medrysone—Hypersensitivity—Fulvestrant—breast cancer	0.000353	0.00983	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—breast cancer	0.000346	0.00758	CbGpPWpGaD
Medrysone—Visual impairment—Tamoxifen—breast cancer	0.000344	0.00956	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptors—PGR—breast cancer	0.000339	0.00744	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—breast cancer	0.000339	0.00743	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—RARB—breast cancer	0.000338	0.0074	CbGpPWpGaD
Medrysone—Pain—Ixabepilone—breast cancer	0.000336	0.00935	CcSEcCtD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—breast cancer	0.000334	0.00732	CbGpPWpGaD
Medrysone—Keratitis—Doxorubicin—breast cancer	0.000333	0.00927	CcSEcCtD
Medrysone—Pain—Anastrozole—breast cancer	0.000316	0.0088	CcSEcCtD
Medrysone—Pain—Letrozole—breast cancer	0.000316	0.0088	CcSEcCtD
Medrysone—Conjunctivitis—Thiotepa—breast cancer	0.000315	0.00877	CcSEcCtD
Medrysone—Visual disturbance—Paclitaxel—breast cancer	0.000313	0.0087	CcSEcCtD
Medrysone—NR3C1—SIDS Susceptibility Pathways—DLX2—breast cancer	0.000309	0.00678	CbGpPWpGaD
Medrysone—Hypersensitivity—Exemestane—breast cancer	0.000307	0.00854	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—breast cancer	0.000302	0.00662	CbGpPWpGaD
Medrysone—Pain—Raloxifene—breast cancer	0.0003	0.00836	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—PABPC1—breast cancer	0.0003	0.00658	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—ESR2—breast cancer	0.000299	0.00655	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—LEP—breast cancer	0.000294	0.00645	CbGpPWpGaD
Medrysone—Hypersensitivity—Ixabepilone—breast cancer	0.00029	0.00806	CcSEcCtD
Medrysone—NR3C1—epithelium—breast cancer	0.000288	0.0496	CbGeAlD
Medrysone—Stinging—Epirubicin—breast cancer	0.000288	0.00802	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—CPT1A—breast cancer	0.000283	0.00621	CbGpPWpGaD
Medrysone—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—breast cancer	0.000283	0.00621	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—breast cancer	0.000281	0.00617	CbGpPWpGaD
Medrysone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—breast cancer	0.00028	0.00615	CbGpPWpGaD
Medrysone—Vision blurred—Goserelin—breast cancer	0.000279	0.00777	CcSEcCtD
Medrysone—Drostanolone—SHBG—breast cancer	0.000279	0.0504	CrCbGaD
Medrysone—NR3C1—skin of body—breast cancer	0.000274	0.0472	CbGeAlD
Medrysone—Hypersensitivity—Anastrozole—breast cancer	0.000273	0.00759	CcSEcCtD
Medrysone—Conjunctivitis—Mitoxantrone—breast cancer	0.000272	0.00758	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—TWIST1—breast cancer	0.000271	0.00594	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—PGR—breast cancer	0.000268	0.00588	CbGpPWpGaD
Medrysone—Stinging—Doxorubicin—breast cancer	0.000267	0.00742	CcSEcCtD
Medrysone—Visual disturbance—Docetaxel—breast cancer	0.000265	0.00738	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptors—AR—breast cancer	0.000264	0.00579	CbGpPWpGaD
Medrysone—Conjunctivitis—Fluorouracil—breast cancer	0.000261	0.00726	CcSEcCtD
Medrysone—Hypersensitivity—Idarubicin—breast cancer	0.000259	0.0072	CcSEcCtD
Medrysone—NR3C1—endometrium—breast cancer	0.000259	0.0445	CbGeAlD
Medrysone—Viral infection—Epirubicin—breast cancer	0.000259	0.00719	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—DKK1—breast cancer	0.000255	0.00559	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—NCOA2—breast cancer	0.00025	0.00549	CbGpPWpGaD
Medrysone—Megestrol acetate—PGR—breast cancer	0.000249	0.0449	CrCbGaD
Medrysone—NR3C1—Adipogenesis—WNT10B—breast cancer	0.000248	0.00543	CbGpPWpGaD
Medrysone—Testosterone Propionate—CYP17A1—breast cancer	0.000246	0.0443	CrCbGaD
Medrysone—Drostanolone—AR—breast cancer	0.000245	0.0442	CrCbGaD
Medrysone—Pain—Chlorambucil—breast cancer	0.000243	0.00677	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—NCOA2—breast cancer	0.000243	0.00533	CbGpPWpGaD
Medrysone—Visual impairment—Irinotecan—breast cancer	0.000242	0.00674	CcSEcCtD
Medrysone—Viral infection—Doxorubicin—breast cancer	0.000239	0.00665	CcSEcCtD
Medrysone—Vision blurred—Thiotepa—breast cancer	0.000239	0.00665	CcSEcCtD
Medrysone—NR3C1—uterus—breast cancer	0.000238	0.041	CbGeAlD
Medrysone—NR3C1—Nuclear Receptors—VDR—breast cancer	0.000237	0.0052	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—ESR2—breast cancer	0.000236	0.00518	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—breast cancer	0.000236	0.00517	CbGpPWpGaD
Medrysone—NR3C1—pituitary gland—breast cancer	0.000234	0.0403	CbGeAlD
Medrysone—NR3C1—adipose tissue—breast cancer	0.000233	0.0401	CbGeAlD
Medrysone—NR3C1—Adipogenesis—NRIP1—breast cancer	0.00023	0.00505	CbGpPWpGaD
Medrysone—Pain—Vinblastine—breast cancer	0.000223	0.0062	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—PTHLH—breast cancer	0.000222	0.00487	CbGpPWpGaD
Medrysone—Conjunctivitis—Paclitaxel—breast cancer	0.000222	0.00618	CcSEcCtD
Medrysone—Drospirenone—PGR—breast cancer	0.000217	0.0392	CrCbGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—breast cancer	0.000217	0.00476	CbGpPWpGaD
Medrysone—Pain—Tamoxifen—breast cancer	0.000217	0.00602	CcSEcCtD
Medrysone—NR3C1—Regulation of Androgen receptor activity—EGR1—breast cancer	0.000214	0.0047	CbGpPWpGaD
Medrysone—NR3C1—female reproductive system—breast cancer	0.000214	0.0369	CbGeAlD
Medrysone—NR3C1—Adipogenesis—MIF—breast cancer	0.000213	0.00466	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—PRLR—breast cancer	0.000213	0.00466	CbGpPWpGaD
Medrysone—Pain—Melphalan—breast cancer	0.000212	0.0059	CcSEcCtD
Medrysone—NR3C1—Regulation of Androgen receptor activity—NCOA1—breast cancer	0.000211	0.00463	CbGpPWpGaD
Medrysone—Hypersensitivity—Chlorambucil—breast cancer	0.00021	0.00583	CcSEcCtD
Medrysone—NR3C1—adrenal gland—breast cancer	0.000209	0.036	CbGeAlD
Medrysone—NR3C1—SIDS Susceptibility Pathways—YBX1—breast cancer	0.000209	0.00458	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—HADHB—breast cancer	0.000209	0.00458	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—AR—breast cancer	0.000209	0.00457	CbGpPWpGaD
Medrysone—Pain—Goserelin—breast cancer	0.000207	0.00575	CcSEcCtD
Medrysone—Vision blurred—Mitoxantrone—breast cancer	0.000206	0.00574	CcSEcCtD
Medrysone—Drostanolone—CYP19A1—breast cancer	0.000205	0.037	CrCbGaD
Medrysone—NR3C1—Circadian Clock—NCOA1—breast cancer	0.000205	0.00449	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—ZNF432—breast cancer	0.000203	0.00444	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—EZH2—breast cancer	0.000202	0.00444	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—AR—breast cancer	0.000202	0.00444	CbGpPWpGaD
Medrysone—NR3C1—bone marrow—breast cancer	0.000202	0.0348	CbGeAlD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—breast cancer	0.000202	0.00443	CbGpPWpGaD
Medrysone—Testosterone Propionate—COMT—breast cancer	0.0002	0.0361	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—THRB—breast cancer	0.000199	0.00437	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—DDIT3—breast cancer	0.000199	0.00436	CbGpPWpGaD
Medrysone—Visual impairment—Paclitaxel—breast cancer	0.000198	0.0055	CcSEcCtD
Medrysone—Vision blurred—Fluorouracil—breast cancer	0.000198	0.0055	CcSEcCtD
Medrysone—NR3C1—female gonad—breast cancer	0.000195	0.0335	CbGeAlD
Medrysone—Hypersensitivity—Vinblastine—breast cancer	0.000192	0.00534	CcSEcCtD
Medrysone—Visual disturbance—Methotrexate—breast cancer	0.000191	0.00532	CcSEcCtD
Medrysone—Conjunctivitis—Docetaxel—breast cancer	0.000188	0.00524	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—VDR—breast cancer	0.000187	0.00411	CbGpPWpGaD
Medrysone—Hypersensitivity—Tamoxifen—breast cancer	0.000187	0.00519	CcSEcCtD
Medrysone—Pain—Vinorelbine—breast cancer	0.000185	0.00515	CcSEcCtD
Medrysone—NR3C1—Regulation of Androgen receptor activity—SIRT1—breast cancer	0.000184	0.00404	CbGpPWpGaD
Medrysone—Hypersensitivity—Melphalan—breast cancer	0.000183	0.00508	CcSEcCtD
Medrysone—Conjunctivitis—Capecitabine—breast cancer	0.000182	0.00507	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—breast cancer	0.000182	0.00398	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—ESR1—breast cancer	0.000181	0.00397	CbGpPWpGaD
Medrysone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—breast cancer	0.000181	0.00397	CbGpPWpGaD
Medrysone—NR3C1—endocrine gland—breast cancer	0.000181	0.0312	CbGeAlD
Medrysone—NR3C1—AP-1 transcription factor network—TCF7L2—breast cancer	0.00018	0.00395	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—GATA3—breast cancer	0.00018	0.00394	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—breast cancer	0.000178	0.00391	CbGpPWpGaD
Medrysone—Hypersensitivity—Goserelin—breast cancer	0.000178	0.00496	CcSEcCtD
Medrysone—Drospirenone—AR—breast cancer	0.000178	0.0321	CrCbGaD
Medrysone—Pain—Thiotepa—breast cancer	0.000177	0.00492	CcSEcCtD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—breast cancer	0.000177	0.00387	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.000172	0.00377	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—breast cancer	0.000172	0.00377	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—NCOR1—breast cancer	0.000172	0.00376	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—EGR1—breast cancer	0.000171	0.00376	CbGpPWpGaD
Medrysone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—breast cancer	0.000169	0.0037	CbGpPWpGaD
Medrysone—Vision blurred—Paclitaxel—breast cancer	0.000168	0.00468	CcSEcCtD
Medrysone—Visual impairment—Docetaxel—breast cancer	0.000168	0.00466	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—breast cancer	0.000163	0.00358	CbGpPWpGaD
Medrysone—Visual impairment—Capecitabine—breast cancer	0.000162	0.00451	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—AHR—breast cancer	0.00016	0.0035	CbGpPWpGaD
Medrysone—Hypersensitivity—Vinorelbine—breast cancer	0.00016	0.00444	CcSEcCtD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—breast cancer	0.000153	0.00335	CbGpPWpGaD
Medrysone—Pain—Mitoxantrone—breast cancer	0.000153	0.00425	CcSEcCtD
Medrysone—Pain—Irinotecan—breast cancer	0.000153	0.00425	CcSEcCtD
Medrysone—Hypersensitivity—Thiotepa—breast cancer	0.000152	0.00424	CcSEcCtD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—breast cancer	0.000152	0.00334	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—breast cancer	0.000151	0.00331	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—breast cancer	0.00015	0.0033	CbGpPWpGaD
Medrysone—Testosterone Propionate—AR—breast cancer	0.000149	0.0269	CrCbGaD
Medrysone—NR3C1—Endoderm Differentiation—SMAD4—breast cancer	0.000149	0.00327	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—PRL—breast cancer	0.000149	0.00326	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—breast cancer	0.000149	0.00326	CbGpPWpGaD
Medrysone—Pain—Gemcitabine—breast cancer	0.000149	0.00414	CcSEcCtD
Medrysone—Drospirenone—BCHE—breast cancer	0.000149	0.0268	CrCbGaD
Medrysone—NR3C1—Adipogenesis—WNT1—breast cancer	0.000146	0.00321	CbGpPWpGaD
Medrysone—Pain—Fluorouracil—breast cancer	0.000146	0.00407	CcSEcCtD
Medrysone—Medroxyprogesterone Acetate—PGR—breast cancer	0.000145	0.0261	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000145	0.00317	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—HIF1A—breast cancer	0.000145	0.00317	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—breast cancer	0.000144	0.00316	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—ESR1—breast cancer	0.000143	0.00314	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—BMP4—breast cancer	0.000142	0.00312	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NR2F1—breast cancer	0.00014	0.00308	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—CSF2—breast cancer	0.00014	0.00307	CbGpPWpGaD
Medrysone—Vision blurred—Capecitabine—breast cancer	0.000138	0.00384	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—TNF—breast cancer	0.000136	0.00298	CbGpPWpGaD
Medrysone—Conjunctivitis—Methotrexate—breast cancer	0.000136	0.00377	CcSEcCtD
Medrysone—Medroxyprogesterone Acetate—SHBG—breast cancer	0.000135	0.0244	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—breast cancer	0.000133	0.00291	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—BMP2—breast cancer	0.000132	0.0029	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—breast cancer	0.000132	0.0029	CbGpPWpGaD
Medrysone—Hypersensitivity—Irinotecan—breast cancer	0.000132	0.00366	CcSEcCtD
Medrysone—Hypersensitivity—Mitoxantrone—breast cancer	0.000132	0.00366	CcSEcCtD
Medrysone—NR3C1—Generic Transcription Pathway—NR2F6—breast cancer	0.000131	0.00286	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—HNF4G—breast cancer	0.000131	0.00286	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.00013	0.00286	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—breast cancer	0.00013	0.00284	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—breast cancer	0.000129	0.00284	CbGpPWpGaD
Medrysone—Methyltestosterone—SHBG—breast cancer	0.000127	0.023	CrCbGaD
Medrysone—Conjunctivitis—Epirubicin—breast cancer	0.000127	0.00353	CcSEcCtD
Medrysone—Hypersensitivity—Fluorouracil—breast cancer	0.000126	0.00351	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—breast cancer	0.000126	0.00276	CbGpPWpGaD
Medrysone—NR3C1—lymph node—breast cancer	0.000125	0.0216	CbGeAlD
Medrysone—Pain—Paclitaxel—breast cancer	0.000125	0.00347	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—GATA3—breast cancer	0.000124	0.00273	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—breast cancer	0.000123	0.0027	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000123	0.0027	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—NCOA2—breast cancer	0.000122	0.00268	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—BAX—breast cancer	0.000122	0.00266	CbGpPWpGaD
Medrysone—Visual impairment—Methotrexate—breast cancer	0.000121	0.00336	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—MMP1—breast cancer	0.00012	0.00264	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—HIF1A—breast cancer	0.000119	0.00262	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—AR—breast cancer	0.000119	0.0214	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—PLAU—breast cancer	0.000118	0.00259	CbGpPWpGaD
Medrysone—Conjunctivitis—Doxorubicin—breast cancer	0.000117	0.00327	CcSEcCtD
Medrysone—Visual impairment—Epirubicin—breast cancer	0.000113	0.00314	CcSEcCtD
Medrysone—Progesterone—CYP17A1—breast cancer	0.000113	0.0204	CrCbGaD
Medrysone—Methyltestosterone—AR—breast cancer	0.000112	0.0202	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—ESR1—breast cancer	0.000111	0.00244	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—SERPINE1—breast cancer	0.000111	0.00243	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—NOTCH1—breast cancer	0.00011	0.00241	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—IL6—breast cancer	0.00011	0.00241	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—APC—breast cancer	0.000108	0.00236	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000108	0.00236	CbGpPWpGaD
Medrysone—Hypersensitivity—Paclitaxel—breast cancer	0.000107	0.00299	CcSEcCtD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—breast cancer	0.000106	0.00232	CbGpPWpGaD
Medrysone—Pain—Docetaxel—breast cancer	0.000106	0.00294	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—breast cancer	0.000105	0.0023	CbGpPWpGaD
Medrysone—Visual impairment—Doxorubicin—breast cancer	0.000105	0.00291	CcSEcCtD
Medrysone—NR3C1—Regulation of Androgen receptor activity—MDM2—breast cancer	0.000103	0.00227	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—NCOA1—breast cancer	0.000103	0.00226	CbGpPWpGaD
Medrysone—Vision blurred—Methotrexate—breast cancer	0.000103	0.00286	CcSEcCtD
Medrysone—Pain—Capecitabine—breast cancer	0.000102	0.00284	CcSEcCtD
Medrysone—Progesterone—ABCC1—breast cancer	0.000102	0.0185	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—FOS—breast cancer	0.0001	0.0022	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—breast cancer	9.94e-05	0.00218	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—breast cancer	9.89e-05	0.00217	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ZNF432—breast cancer	9.76e-05	0.00214	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—ESR2—breast cancer	9.66e-05	0.00212	CbGpPWpGaD
Medrysone—Vision blurred—Epirubicin—breast cancer	9.62e-05	0.00268	CcSEcCtD
Medrysone—Hydrocortisone—SHBG—breast cancer	9.6e-05	0.0173	CrCbGaD
Medrysone—Methyltestosterone—CYP19A1—breast cancer	9.35e-05	0.0169	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—ESRRA—breast cancer	9.31e-05	0.00204	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—STAT5A—breast cancer	9.18e-05	0.00201	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—ESR1—breast cancer	9.14e-05	0.0165	CrCbGaD
Medrysone—Hypersensitivity—Docetaxel—breast cancer	9.1e-05	0.00253	CcSEcCtD
Medrysone—NR3C1—SIDS Susceptibility Pathways—EGR1—breast cancer	9.03e-05	0.00198	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—JUN—breast cancer	8.99e-05	0.00197	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—breast cancer	8.92e-05	0.00195	CbGpPWpGaD
Medrysone—Vision blurred—Doxorubicin—breast cancer	8.9e-05	0.00248	CcSEcCtD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—FOS—breast cancer	8.83e-05	0.00194	CbGpPWpGaD
Medrysone—Hypersensitivity—Capecitabine—breast cancer	8.81e-05	0.00245	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—NCOR1—breast cancer	8.63e-05	0.00189	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—AR—breast cancer	8.53e-05	0.00187	CbGpPWpGaD
Medrysone—Finasteride—CYP3A4—breast cancer	8.51e-05	0.0154	CrCbGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—MAPK8—breast cancer	8.51e-05	0.00186	CbGpPWpGaD
Medrysone—Hydrocortamate—CYP3A4—breast cancer	8.44e-05	0.0152	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—THRB—breast cancer	8.42e-05	0.00184	CbGpPWpGaD
Medrysone—Progesterone—PGR—breast cancer	8.36e-05	0.0151	CrCbGaD
Medrysone—NR3C1—Adipogenesis—E2F1—breast cancer	8.35e-05	0.00183	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—IFNG—breast cancer	8.32e-05	0.00182	CbGpPWpGaD
Medrysone—Cortisone acetate—CYP3A4—breast cancer	8.31e-05	0.015	CrCbGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—breast cancer	8.13e-05	0.00178	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—RXRB—breast cancer	8.07e-05	0.00177	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—SRC—breast cancer	8.06e-05	0.00177	CbGpPWpGaD
Medrysone—Progesterone—SHBG—breast cancer	7.82e-05	0.0141	CrCbGaD
Medrysone—Progesterone—CYP1B1—breast cancer	7.82e-05	0.0141	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—CXCL8—breast cancer	7.74e-05	0.0017	CbGpPWpGaD
Medrysone—Pain—Methotrexate—breast cancer	7.61e-05	0.00212	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—CDKN1B—breast cancer	7.56e-05	0.00166	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—HES1—breast cancer	7.5e-05	0.00164	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—IL2—breast cancer	7.4e-05	0.00162	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HNRNPR—breast cancer	7.39e-05	0.00162	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HNRNPK—breast cancer	7.39e-05	0.00162	CbGpPWpGaD
Medrysone—Testosterone—SHBG—breast cancer	7.39e-05	0.0133	CrCbGaD
Medrysone—Testosterone—CYP1B1—breast cancer	7.39e-05	0.0133	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—breast cancer	7.33e-05	0.00161	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—CTNNB1—breast cancer	7.31e-05	0.0016	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—breast cancer	7.29e-05	0.0016	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—HIF1A—breast cancer	7.27e-05	0.00159	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—RELA—breast cancer	7.24e-05	0.00159	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	7.21e-05	0.00158	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—JUN—breast cancer	7.2e-05	0.00158	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	7.14e-05	0.00157	CbGpPWpGaD
Medrysone—Pain—Epirubicin—breast cancer	7.12e-05	0.00198	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—LEP—breast cancer	7.1e-05	0.00156	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	7e-05	0.00153	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	6.96e-05	0.00153	CbGpPWpGaD
Medrysone—Progesterone—AR—breast cancer	6.85e-05	0.0124	CrCbGaD
Medrysone—Drospirenone—PTGS2—breast cancer	6.85e-05	0.0124	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	6.82e-05	0.0015	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—EEF1B2—breast cancer	6.76e-05	0.00148	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NR2F1—breast cancer	6.76e-05	0.00148	CbGpPWpGaD
Medrysone—Megestrol acetate—ABCB1—breast cancer	6.67e-05	0.012	CrCbGaD
Medrysone—Hydrocortisone—ABCG2—breast cancer	6.62e-05	0.0119	CrCbGaD
Medrysone—Pain—Doxorubicin—breast cancer	6.59e-05	0.00183	CcSEcCtD
Medrysone—Hypersensitivity—Methotrexate—breast cancer	6.56e-05	0.00182	CcSEcCtD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	6.52e-05	0.00143	CbGpPWpGaD
Medrysone—Paramethasone—CYP3A4—breast cancer	6.5e-05	0.0117	CrCbGaD
Medrysone—Testosterone—AR—breast cancer	6.48e-05	0.0117	CrCbGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	6.4e-05	0.0014	CbGpPWpGaD
Medrysone—Fluorometholone—CYP3A4—breast cancer	6.35e-05	0.0115	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	6.34e-05	0.00139	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HNF4G—breast cancer	6.29e-05	0.00138	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NR2F6—breast cancer	6.29e-05	0.00138	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	6.28e-05	0.00138	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	6.21e-05	0.00136	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	6.15e-05	0.00135	CbGpPWpGaD
Medrysone—Hypersensitivity—Epirubicin—breast cancer	6.14e-05	0.00171	CcSEcCtD
Medrysone—Methylprednisolone—CYP3A4—breast cancer	6.13e-05	0.0111	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	6e-05	0.00132	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—RB1—breast cancer	5.92e-05	0.0013	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	5.91e-05	0.00129	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—IGF1—breast cancer	5.87e-05	0.00129	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—RARB—breast cancer	5.83e-05	0.00128	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	5.82e-05	0.00127	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—MYC—breast cancer	5.78e-05	0.00127	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	5.77e-05	0.00126	CbGpPWpGaD
Medrysone—Hypersensitivity—Doxorubicin—breast cancer	5.68e-05	0.00158	CcSEcCtD
Medrysone—NR3C1—Gene Expression—HNRNPL—breast cancer	5.6e-05	0.00123	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—MED12—breast cancer	5.59e-05	0.00123	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—SERPINE1—breast cancer	5.57e-05	0.00122	CbGpPWpGaD
Medrysone—Testosterone—CYP19A1—breast cancer	5.42e-05	0.00979	CrCbGaD
Medrysone—Progesterone—ESR1—breast cancer	5.28e-05	0.00953	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	5.24e-05	0.00115	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	5.15e-05	0.00113	CbGpPWpGaD
Medrysone—Methylprednisolone—ABCB1—breast cancer	5.11e-05	0.00922	CrCbGaD
Medrysone—Testosterone—ABCG2—breast cancer	5.1e-05	0.0092	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	5.07e-05	0.00111	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—TP53—breast cancer	4.75e-05	0.00104	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—CYP3A4—breast cancer	4.67e-05	0.00842	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—PGR—breast cancer	4.63e-05	0.00102	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—EIF2S2—breast cancer	4.62e-05	0.00101	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ESRRA—breast cancer	4.48e-05	0.000982	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	4.46e-05	0.000978	CbGpPWpGaD
Medrysone—Methyltestosterone—CYP3A4—breast cancer	4.39e-05	0.00793	CrCbGaD
Medrysone—NR3C1—Adipogenesis—CTNNB1—breast cancer	4.35e-05	0.000954	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—IL6—breast cancer	4.35e-05	0.000953	CbGpPWpGaD
Medrysone—Prednisolone—CYP3A4—breast cancer	4.32e-05	0.00781	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	4.31e-05	0.000944	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	4.31e-05	0.000944	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—CDKN1A—breast cancer	4.25e-05	0.000932	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—YBX1—breast cancer	4.25e-05	0.000931	CbGpPWpGaD
Medrysone—Progesterone—CYP1A1—breast cancer	4.22e-05	0.00762	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	4.19e-05	0.000917	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	4.08e-05	0.000894	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	4.08e-05	0.000894	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—EEF2—breast cancer	4.05e-05	0.000888	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—THRB—breast cancer	4.05e-05	0.000888	CbGpPWpGaD
Medrysone—Testosterone—CYP1A1—breast cancer	3.99e-05	0.0072	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	3.91e-05	0.000857	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	3.9e-05	0.000855	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RXRB—breast cancer	3.88e-05	0.000852	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—TET2—breast cancer	3.88e-05	0.000852	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	3.86e-05	0.000847	CbGpPWpGaD
Medrysone—Methyltestosterone—ALB—breast cancer	3.83e-05	0.00692	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	3.83e-05	0.00084	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPL31—breast cancer	3.81e-05	0.000835	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—STAT3—breast cancer	3.79e-05	0.000832	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	3.79e-05	0.000831	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	3.76e-05	0.000825	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	3.76e-05	0.000824	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—AR—breast cancer	3.6e-05	0.00079	CbGpPWpGaD
Medrysone—Prednisolone—ABCB1—breast cancer	3.6e-05	0.0065	CrCbGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	3.57e-05	0.000782	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPS4X—breast cancer	3.55e-05	0.000779	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	3.53e-05	0.000775	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—TGFB1—breast cancer	3.52e-05	0.000771	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—EIF3A—breast cancer	3.5e-05	0.000767	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—DNMT3A—breast cancer	3.45e-05	0.000755	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ELL—breast cancer	3.4e-05	0.000744	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	3.31e-05	0.000726	CbGpPWpGaD
Medrysone—Hydrocortisone—CYP3A4—breast cancer	3.31e-05	0.00597	CrCbGaD
Medrysone—NR3C1—Adipogenesis—TNF—breast cancer	3.28e-05	0.00072	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	3.24e-05	0.000711	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—VDR—breast cancer	3.24e-05	0.00071	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	3.15e-05	0.000691	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PABPC1—breast cancer	3.14e-05	0.000689	CbGpPWpGaD
Medrysone—Progesterone—CYP2D6—breast cancer	3.14e-05	0.00567	CrCbGaD
Medrysone—NR3C1—Gene Expression—DNMT3B—breast cancer	2.94e-05	0.000645	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPL23A—breast cancer	2.89e-05	0.000633	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	2.84e-05	0.000622	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HIST1H2BK—breast cancer	2.83e-05	0.000621	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HIST1H2BC—breast cancer	2.83e-05	0.000621	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RARB—breast cancer	2.81e-05	0.000616	CbGpPWpGaD
Medrysone—Hydrocortisone—ABCB1—breast cancer	2.75e-05	0.00497	CrCbGaD
Medrysone—Progesterone—CYP3A4—breast cancer	2.69e-05	0.00486	CrCbGaD
Medrysone—NR3C1—Gene Expression—RPS8—breast cancer	2.69e-05	0.00059	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPS7—breast cancer	2.69e-05	0.00059	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—MED12—breast cancer	2.69e-05	0.00059	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—IL6—breast cancer	2.65e-05	0.000581	CbGpPWpGaD
Medrysone—Testosterone—CYP3A4—breast cancer	2.55e-05	0.0046	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	2.47e-05	0.000542	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NOTCH4—breast cancer	2.44e-05	0.000535	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	2.39e-05	0.000524	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HSPA1B—breast cancer	2.33e-05	0.00051	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	2.29e-05	0.000502	CbGpPWpGaD
Medrysone—Progesterone—ABCB1—breast cancer	2.24e-05	0.00405	CrCbGaD
Medrysone—NR3C1—Gene Expression—PGR—breast cancer	2.23e-05	0.000489	CbGpPWpGaD
Medrysone—Testosterone—ALB—breast cancer	2.22e-05	0.00401	CrCbGaD
Medrysone—NR3C1—Gene Expression—DNMT1—breast cancer	2.19e-05	0.00048	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NCOA2—breast cancer	2.15e-05	0.000471	CbGpPWpGaD
Medrysone—Testosterone—ABCB1—breast cancer	2.12e-05	0.00383	CrCbGaD
Medrysone—NR3C1—Gene Expression—EZH2—breast cancer	2.12e-05	0.000465	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NOTCH3—breast cancer	2.07e-05	0.000455	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PARP1—breast cancer	2.07e-05	0.000455	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	2.03e-05	0.000446	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPS6—breast cancer	2.02e-05	0.000444	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ESR2—breast cancer	1.96e-05	0.000431	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NOTCH2—breast cancer	1.86e-05	0.000408	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NCOA1—breast cancer	1.81e-05	0.000397	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—AR—breast cancer	1.74e-05	0.00038	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SIRT1—breast cancer	1.58e-05	0.000347	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SMAD4—breast cancer	1.56e-05	0.000342	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—VDR—breast cancer	1.56e-05	0.000342	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NCOR1—breast cancer	1.52e-05	0.000332	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—H2AFX—breast cancer	1.48e-05	0.000324	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ERCC2—breast cancer	1.43e-05	0.000313	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—MYC—breast cancer	1.29e-05	0.000282	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ESR1—breast cancer	1.19e-05	0.000261	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NOTCH1—breast cancer	1.15e-05	0.000252	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SERPINE1—breast cancer	9.79e-06	0.000215	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—MAPK3—breast cancer	6.37e-06	0.00014	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—MYC—breast cancer	6.2e-06	0.000136	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—AKT1—breast cancer	4.3e-06	9.42e-05	CbGpPWpGaD
